Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Gene augmentation of LCA5-associated Leber congenital amaurosis ameliorates bulge region defects of the photoreceptor ciliary axoneme
Siebren Faber, Olivier Mercey, Katrin Junger, Alejandro Garanto, Helen May-Simera, Marius Ueffing, Rob W.J. Collin, Karsten Boldt, Paul Guichard, Virginie Hamel, Ronald Roepman
Siebren Faber, Olivier Mercey, Katrin Junger, Alejandro Garanto, Helen May-Simera, Marius Ueffing, Rob W.J. Collin, Karsten Boldt, Paul Guichard, Virginie Hamel, Ronald Roepman
View: Text | PDF
Research Article Cell biology Genetics

Gene augmentation of LCA5-associated Leber congenital amaurosis ameliorates bulge region defects of the photoreceptor ciliary axoneme

  • Text
  • PDF
Abstract

Leber congenital amaurosis (LCA) is a group of inherited retinal diseases characterized by early-onset, rapid loss of photoreceptor cells. Despite the discovery of a growing number of genes associated with this disease, the molecular mechanisms of photoreceptor cell degeneration of most LCA subtypes remain poorly understood. Here, using retina-specific affinity proteomics combined with ultrastructure expansion microscopy, we reveal the structural and molecular defects underlying LCA type 5 (LCA5) with nanoscale resolution. We show that LCA5-encoded lebercilin, together with retinitis pigmentosa 1 protein (RP1) and the intraflagellar transport (IFT) proteins IFT81 and IFT88, localized at the bulge region of the photoreceptor outer segment (OS), a region crucial for OS membrane disc formation. Next, we demonstrate that mutant mice deficient in lebercilin exhibited early axonemal defects at the bulge region and the distal OS, accompanied by reduced levels of RP1 and IFT proteins, affecting membrane disc formation and presumably leading to photoreceptor death. Finally, adeno-associated virus–based LCA5 gene augmentation partially restored the bulge region, preserved OS axoneme structure and membrane disc formation, and resulted in photoreceptor cell survival. Our approach thus provides a next level of assessment of retinal (gene) therapy efficacy at the molecular level.

Authors

Siebren Faber, Olivier Mercey, Katrin Junger, Alejandro Garanto, Helen May-Simera, Marius Ueffing, Rob W.J. Collin, Karsten Boldt, Paul Guichard, Virginie Hamel, Ronald Roepman

×

Figure 7

Schematic representation of Lca5+/gt (HET), Lca5gt/gt (HOM), and gene therapy–treated photoreceptors.

Options: View larger image (or click on image) Download as PowerPoint
Schematic representation of Lca5+/gt (HET), Lca5gt/gt (HOM), and gene th...
In unaffected HET photoreceptors (left), lebercilin (LCA5; orange) localizes predominantly at the proximal part of the bulge region, between CEP290 (cyan, at the level of the Y-links) and RP1 (gray, distal axonemal protein). IFT81 (yellow) localizes to the same bulge proximal region as LCA5, but also accumulates above the basal body and to a lesser extent along the CC. In HOM photoreceptors (middle), the CC is extended, as illustrated by an elongated CEP290 and POC5 (green) signal. Furthermore, bulge formation and distal axoneme organization is disrupted, leading to rhodopsin (RHO, bright green) mis-trafficking, with accumulation above the basal body, localization along the CC, and inside vesicle-like structures. Moreover, LCA5 loss leads to decreased levels of IFT81 and RP1 at the bulge region and more dispersed localization along the distal axoneme. AAV-LCA5 gene augmentation therapy (right) partially restores bulge formation, CC and distal axoneme organization, as well as RP1 and rhodopsin localization. IFT81 localization is restored to a lesser extent, possibly explained by the ectopic LCA5 expression along the distal axoneme.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts